Literature DB >> 6097548

Outbreak of persistent, unexplained, generalized lymphadenopathy with immunological abnormalities in drug addicts in Milan.

A Lazzarin, M Galli, M Introna, C Negri, A Mantovani, L Mella, P Ferrante, C Parravicini, M Trombini, F Aiuti.   

Abstract

Persistent unexplained lymphadenopathy (LAS) with intermittent fever, weight loss, night sweats and malaise was observed from March to October 1983 in 16 of 133 intravenous drug addicts who had been followed for at least two years in a Center for Drug Addicts Assistance in Milan, Italy. All the subjects lived in a restricted suburban area and indulged in frequent toxicomanic practices and mutual sexual intercourse. The subjects showed immunological alterations such as lymphopenia (50%), decreased T helper/T suppressor ratio (93%), both these abnormalities (43%), decreased T helper cells (75%), increased T suppressor cytotoxic cells (81%), decreased natural killer (NK) activity (77%), anergy (50%) or hypoergy (43%) to recall skin testing and elevated levels of IgG (87%). Anti-HTLV III antibodies were found in 14 of 16 (87%) patients with LAS and in 3 of 11 (27%) symptom-free drug addicts belonging to the same group. It will be important to assess in the future whether this clinical and immunological picture results in acquired immunodeficiency syndrome in an area so far untouched by this disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6097548     DOI: 10.1007/bf01645217

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  27 in total

1.  Pneumocystis pneumonia--Los Angeles.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1981-06-05       Impact factor: 17.586

Review 2.  AIDS in Europe.

Authors:  P Ebbesen; R J Biggar; M Melbye
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-05

Review 3.  NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations.

Authors:  A S Fauci; A M Macher; D L Longo; H C Lane; A H Rook; H Masur; E P Gelmann
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

4.  Pneumocystis carinii pneumonia among persons with hemophilia A.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1982-07-16       Impact factor: 17.586

5.  [Multipuncture: a simple test for cell immunity at the patient's bedside. Determination of a reference population (author's transl)].

Authors:  B Lesourd; M Roumiantzeff; J Wisniack; G Biron; J Loeper; R Moulias
Journal:  Nouv Presse Med       Date:  1980-11-29

6.  Immunoperoxidase evaluation of lymph nodes from acquired immune deficiency patients.

Authors:  M Mangkornkanok-Mark; A S Mark; J Dong
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

7.  Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.

Authors:  B Safai; M G Sarngadharan; J E Groopman; K Arnett; M Popovic; A Sliski; J Schüpbach; R C Gallo
Journal:  Lancet       Date:  1984-06-30       Impact factor: 79.321

8.  Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti.

Authors:  J W Pape; B Liautaud; F Thomas; J R Mathurin; M M St Amand; M Boncy; V Pean; M Pamphile; A C Laroche; W D Johnson
Journal:  N Engl J Med       Date:  1983-10-20       Impact factor: 91.245

9.  Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders.

Authors:  J L Fahey; H Prince; M Weaver; J Groopman; B Visscher; K Schwartz; R Detels
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

10.  Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome.

Authors:  C Harris; C B Small; R S Klein; G H Friedland; B Moll; E E Emeson; I Spigland; N H Steigbigel
Journal:  N Engl J Med       Date:  1983-05-19       Impact factor: 91.245

View more
  5 in total

1.  Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome.

Authors:  G Poli; M Introna; F Zanaboni; G Peri; M Carbonari; F Aiuti; A Lazzarin; M Moroni; A Mantovani
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

2.  Epidemic of LAV/HTLV III infection in drug addicts in Milan: serological survey and clinical follow-up.

Authors:  A Lazzarin; M Galli; D Geroldi; A Zanetti; P Crocchiolo; F Aiuti; M Moroni
Journal:  Infection       Date:  1985 Sep-Oct       Impact factor: 3.553

3.  Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis.

Authors:  G Poli; B Bottazzi; R Acero; L Bersani; V Rossi; M Introna; A Lazzarin; M Galli; A Mantovani
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

4.  Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome.

Authors:  A Lazzarin; C Uberti Foppa; M Galli; A Mantovani; G Poli; F Franzetti; R Nóvati
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

5.  IgM, IgG and IgA rheumatoid factors and circulating immune complexes in patients with AIDS and AIDS-related complex with serological abnormalities.

Authors:  S Procaccia; A Lazzarin; A Colucci; A Gasparini; P Forcellini; D Lanzanova; C U Foppa; R Novati; C Zanussi
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.